MICHAEL GARY JONES, D.O.
Medical Practice in Pocatello, ID
License number
Idaho O0428
Category
Medical Practice
Type
Obstetrics & Gynecology
Address
Address
777 Hospital Way Bldg A SUITE 300, Pocatello, ID 83201
Phone
(208) 232-6100
Professional information
Dr. Michael G Jones, Malad City ID - DO (Doctor of Osteopathic Medicine)
Specialties:
Obstetrics & Gynecology
Address:
150 N 200 W, Malad City 83252
(208) 766-2231 (Phone)
Pocatello Women's Health Clinic
777 Hospital Way STE 300, Pocatello 83201
(208) 232-6100 (Phone)
500 S 11Th Ave STE 4C, Pocatello 83201
(208) 232-3103 (Phone)
(208) 766-2231 (Phone)
Pocatello Women's Health Clinic
777 Hospital Way STE 300, Pocatello 83201
(208) 232-6100 (Phone)
500 S 11Th Ave STE 4C, Pocatello 83201
(208) 232-3103 (Phone)
Certifications:
Obstetrics & Gynecology, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
150 N 200 W, Malad City 83252
500 S 11Th Ave STE 4C, Pocatello 83201
Pocatello Women's Health Clinic
777 Hospital Way STE 300, Pocatello 83201
Oneida County Hospital
150 North 200 West, Malad City 83252
Portneuf Medical Center
651 Memorial Dr, Pocatello 83201
500 S 11Th Ave STE 4C, Pocatello 83201
Pocatello Women's Health Clinic
777 Hospital Way STE 300, Pocatello 83201
Oneida County Hospital
150 North 200 West, Malad City 83252
Portneuf Medical Center
651 Memorial Dr, Pocatello 83201
Education:
Medical School
Arizona College Of Osteopathic Medicine Of Midwestern University, Midwestern University
Graduated: 2002
Arizona College Of Osteopathic Medicine Of Midwestern University, Midwestern University
Graduated: 2002
Michael Gary Jones, Pocatello ID
Specialties:
OB-GYN
Address:
777 Hospital Way, Pocatello, ID 83201
Polymeric Media Comprising Polybenzimidazoles N-Substituted With Organic-Inorganic Hybrid Moiety
US Patent:
7632898, Dec 15, 2009
Filed:
Jul 3, 2007
Appl. No.:
11/772872
Inventors:
John R. Klaehn - Idaho Falls ID, US
Eric S. Peterson - Idaho Falls ID, US
Alan K. Wertsching - Idaho Falls ID, US
Christopher J. Orme - Shelley ID, US
Thomas A. Luther - Idaho Falls ID, US
Michael G. Jones - Pocatello ID, US
Eric S. Peterson - Idaho Falls ID, US
Alan K. Wertsching - Idaho Falls ID, US
Christopher J. Orme - Shelley ID, US
Thomas A. Luther - Idaho Falls ID, US
Michael G. Jones - Pocatello ID, US
Assignee:
Battelle Energy Alliance, LLC - Idaho Falls ID
International Classification:
C08G 70/10, B01D 59/12
US Classification:
525540, 96 14, 95 45, 525933
Abstract:
A PBI compound includes imidazole nitrogens at least a portion of which are substituted with an organic-inorganic hybrid moiety may be included in a separatory medium. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)MeSiCH— where R is selected from among methyl, phenyl, vinyl, and allyl. The separatory medium may exhibit an H, Ar, N, O, CH, or COgas permeability greater than the gas permeability of a comparable separatory medium comprising the PBI compound without substitution. The separatory medium may further include an electronically conductive medium and/or an ionically conductive medium. The separatory medium may be used as a membrane (semi-permeable, permeable, and non-permeable), a barrier, an ion exchange media, a filter, a gas chromatography coating (such as stationary phase coating in affinity chromatography), etc.
Polybenzimidazole Compounds, Polymeric Media, And Methods Of Post-Polymerization Modifications
US Patent:
7259230, Aug 21, 2007
Filed:
Jun 7, 2004
Appl. No.:
10/862921
Inventors:
John R. Klaehn - Idaho Falls ID, US
Eric S. Peterson - Idaho Falls ID, US
Alan K. Wertsching - Idaho Falls ID, US
Christopher J. Orme - Shelley ID, US
Thomas A. Luther - Idaho Falls ID, US
Michael G. Jones - Pocatello ID, US
Eric S. Peterson - Idaho Falls ID, US
Alan K. Wertsching - Idaho Falls ID, US
Christopher J. Orme - Shelley ID, US
Thomas A. Luther - Idaho Falls ID, US
Michael G. Jones - Pocatello ID, US
Assignee:
Battelle Energy Alliance, LLC - Idaho Falls ID
International Classification:
C08G 73/18
US Classification:
528423, 528398, 528472, 528485, 528487, 528488, 528503, 524858, 524869, 525540
Abstract:
A PBI compound includes imidazole nitrogens at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)MeSiCH— where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least 5 equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about 15.
Polybenzimidazole Compounds, Polymeric Media, And Methods Of Post-Polymerization Modifications
US Patent:
7309758, Dec 18, 2007
Filed:
Oct 19, 2004
Appl. No.:
10/969456
Inventors:
John R. Klaehn - Idaho Falls ID, US
Eric S. Peterson - Idaho Falls ID, US
Christopher J. Orme - Shelley ID, US
Michael G. Jones - Chubbuck ID, US
Alan K. Wertsching - Idaho Falls ID, US
Thomas A. Luther - Idaho Falls ID, US
Tammy L. Trowbridge - Idaho Falls ID, US
Eric S. Peterson - Idaho Falls ID, US
Christopher J. Orme - Shelley ID, US
Michael G. Jones - Chubbuck ID, US
Alan K. Wertsching - Idaho Falls ID, US
Thomas A. Luther - Idaho Falls ID, US
Tammy L. Trowbridge - Idaho Falls ID, US
Assignee:
Battelle Energy Alliance, LLC - Idaho Falls ID
International Classification:
C08G 73/18
US Classification:
528423, 528220, 528228, 528398, 528482, 528485, 528487, 528488, 528503, 525540
Abstract:
A PBI compound includes imidazole nitrogens at least a portion of which are substituted with a moiety containing a carbonyl group, the substituted imidazole nitrogens being bonded to carbon of the carbonyl group. At least 85% of the nitrogens may be substituted. The carbonyl-containing moiety may include RCO—, where R is alkoxy or haloalkyl. The PBI compound may exhibit a first temperature marking an onset of weight loss corresponding to reversion of the substituted PBI that is less than a second temperature marking an onset of decomposition of an otherwise identical PBI compound without the substituted moiety. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may use more than 5 equivalents in relation to the imidazole nitrogens to be substituted.
Polybenzimidazole Compounds
US Patent:
7772361, Aug 10, 2010
Filed:
Jul 3, 2007
Appl. No.:
11/772868
Inventors:
John R. Klaehn - Idaho Falls ID, US
Eric S. Peterson - Idaho Falls ID, US
Alan K. Wertsching - Idaho Falls ID, US
Christopher J. Orme - Shelley ID, US
Thomas A. Luther - Idaho Falls ID, US
Michael G. Jones - Pocatello ID, US
Eric S. Peterson - Idaho Falls ID, US
Alan K. Wertsching - Idaho Falls ID, US
Christopher J. Orme - Shelley ID, US
Thomas A. Luther - Idaho Falls ID, US
Michael G. Jones - Pocatello ID, US
Assignee:
Battelle Energy Alliance, LLC - Idaho Falls ID
International Classification:
C08G 73/18, C08G 73/06
US Classification:
528423, 528398, 528482, 528485, 528487, 528488, 528503, 524858, 524869, 525540
Abstract:
A PBI compound that includes imidazole nitrogens, at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)MeSiCH—, where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least five equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about fifteen equivalents.
Polybenzimidazole Compounds
US Patent:
8063174, Nov 22, 2011
Filed:
Nov 1, 2007
Appl. No.:
11/933604
Inventors:
John R. Klaehn - Idaho Falls ID, US
Eric S. Peterson - Idaho Falls ID, US
Christopher J. Orme - Shelley ID, US
Michael G. Jones - Chubbuck ID, US
Alan K. Wertsching - Idaho Falls ID, US
Thomas A. Luther - Idaho Falls ID, US
Tammy L. Trowbridge - Idaho Falls ID, US
Eric S. Peterson - Idaho Falls ID, US
Christopher J. Orme - Shelley ID, US
Michael G. Jones - Chubbuck ID, US
Alan K. Wertsching - Idaho Falls ID, US
Thomas A. Luther - Idaho Falls ID, US
Tammy L. Trowbridge - Idaho Falls ID, US
Assignee:
Battelle Energy Alliance, LLC - Idaho Falls ID
International Classification:
C08G 73/18, C08G 73/06, C08G 12/00
US Classification:
528423, 528220, 528228, 528398, 528482, 528485, 528487, 528488, 528503, 525540
Abstract:
A PBI compound includes imidazole nitrogens at least a portion of which are substituted with a moiety containing a carbonyl group, the substituted imidazole nitrogens being bonded to carbon of the carbonyl group. At least 85% of the nitrogens may be substituted. The carbonyl-containing moiety may include RCO—, where R is alkoxy or haloalkyl. The PBI compound may exhibit a first temperature marking an onset of weight loss corresponding to reversion of the substituted PBI that is less than a second temperature marking an onset of decomposition of an otherwise identical PBI compound without the substituted moiety. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may use more than 5 equivalents in relation to the imidazole nitrogens to be substituted.
Tissue Fixation Device
US Patent:
2013028, Oct 31, 2013
Filed:
May 15, 2012
Appl. No.:
13/472297
Inventors:
Michael Jones - Chubbuck ID, US
Nathan O. Plowman - Wellsville UT, US
Nathan Erickson - Beaver Dam UT, US
Andrew R. Fauth - River Heights UT, US
Daniel J. Triplett - Providence UT, US
Darin Ewer - Providence UT, US
Jason M. Glad - Lewiston UT, US
Nathan O. Plowman - Wellsville UT, US
Nathan Erickson - Beaver Dam UT, US
Andrew R. Fauth - River Heights UT, US
Daniel J. Triplett - Providence UT, US
Darin Ewer - Providence UT, US
Jason M. Glad - Lewiston UT, US
Assignee:
IMDS CORPORATION - Logan UT
International Classification:
A61B 17/03
US Classification:
606151
Abstract:
Tissue fixation members interact with a housing to hold tissue relative to the housing and allow the orientation and position of the grasped tissue to be manipulated with improved efficacy. The tissue fixation members can be easily and quickly moved between deployed and retracted positions to reversibly grasp and release tissue.
Polymeric Medium
US Patent:
8129498, Mar 6, 2012
Filed:
Nov 1, 2007
Appl. No.:
11/933652
Inventors:
John R. Klaehn - Idaho Falls ID, US
Eric S. Peterson - Idaho Falls ID, US
Christopher J. Orme - Shelley ID, US
Michael G. Jones - Chubbuck ID, US
Alan K. Wertsching - Idaho Falls ID, US
Thomas A. Luther - Idaho Falls ID, US
Tammy L. Trowbridge - Idaho Falls ID, US
Eric S. Peterson - Idaho Falls ID, US
Christopher J. Orme - Shelley ID, US
Michael G. Jones - Chubbuck ID, US
Alan K. Wertsching - Idaho Falls ID, US
Thomas A. Luther - Idaho Falls ID, US
Tammy L. Trowbridge - Idaho Falls ID, US
Assignee:
Battelle Energy Alliance, LLC - Idaho Falls ID
International Classification:
C08G 73/18, C08G 73/00
US Classification:
528423, 528220, 528228, 528398, 528482, 528485, 528487, 528488, 528503, 525540
Abstract:
A PBI compound includes imidazole nitrogens at least a portion of which are substituted with a moiety containing a carbonyl group, the substituted imidazole nitrogens being bonded to carbon of the carbonyl group. At least 85% of the nitrogens may be substituted. The carbonyl-containing moiety may include RCO—, where R is alkoxy or haloalkyl. The PBI compound may exhibit a first temperature marking an onset of weight loss corresponding to reversion of the substituted PBI that is less than a second temperature marking an onset of decomposition of an otherwise identical PBI compound without the substituted moiety. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may use more than 5 equivalents in relation to the imidazole nitrogens to be substituted.